Aurora Cannabis And Willow Biosciences Resolve Patent Clash

Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) announced Tuesday that it had successfully completed a confidential settlement ‎resolving an ongoing patent litigation with Willow Biosciences Inc. (OTCQB:

Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB) announced Tuesday that it had successfully completed a confidential settlement ‎resolving an ongoing patent litigation with Willow Biosciences Inc. (OTCQB:CANSF) (TSX:WLLW). 

Aurora undertook the patent infringement action in July 2021, alleging that Willow’s biosynthetic process for synthesizing cannabinoids infringed Aurora’s exclusive rights to patents co-owned by the University of Saskatchewan and the National Research Council (NRC).

The technology of the asserted patents was invented by Anandia co-founder and former chief science officer at Aurora, Jonathan Page and his colleagues, following their work at the University of Saskatchewan and the NRC. They identified key enzymes and corresponding genes in the biosynthetic pathways of cannabis plants.

In December 2022, Willow announced that it had consolidated its R&D operations, transferring equipment and key personnel from its Canadian facilities to Mountain View, California.

“We are pleased with the negotiated settlement, which provides Aurora a favorable resolution that ensures our Canadian cannabis-related patent rights are respected,” Miguel Martin, CEO of Aurora said. “Aurora is a pioneer in terms of the company’s genetics work in the Canadian cannabis industry and will not hesitate to continue to take the steps necessary, including legal action, to protect and enforce our intellectual property rights when necessary.”

ACB Price Action

Aurora’s shares traded 0.8728% higher at $0.4276 per share at the time of writing on Tuesday morning.
Did you miss the first wave of cannabis investments? Don’t make that mistake again.
Experts believe cannabis stocks have found their floor and are now poised for unprecedented growth. Join Benzinga PotProfits. Benefit from Michael Berger’s sharp analysis, revealing top cannabis stock opportunities and timely updates. Experience the potential of 10%+ returns in just 90 days. Our 4.5-star Marketfy rating speaks volumes. Secure your position in this booming sector with a 30-day money-back guarantee. The time to invest is now, before everyone else realizes it. Secure your profits with Benzinga. Click here now to learn more.

  • Aurora And Curaleaf Cannabis Companies Each Close Multi-Million Dollar Funding Deals
  • Aurora Stock Plunges On $25M Bought Deal To Repay Convertible Debt
  • Aurora Cannabis Launches New Brand At Toronto Hall of Flowers, This Is What Innovation Looks Like

Photo: Courtesy of succo, mrkukuruznik5 by Pixabay

Total
0
Shares
Related Posts
Read More

Elizabeth Warren Questions CFTC Chair On Frequent Interactions With Jailed FTX Founder Sam Bankman-Fried: Provide ‘Full Accounting Of All Conversations’

Senator Warren and Grassley have issued a letter to Behnam asking for a comprehensive record of his interactions with Bankman-Fried during his tenure. This request comes in the wake of disclosures that CFTC officials had met with Bankman-Fried and his team as many as 10 times at the agency over a span of 14 months.

TSLA

Read More

Stratasys Files Preliminary Form F-4 And Additional Revenue And EBITDA Estimates For Superior Value Combination With Desktop Metal; Combined Co Expected To Generate More Than $1.6B Of Revenue And More Than $300M Of EBITDA In 2026 At Base Case

Transaction Will Form Additive Manufacturing Leader with Comprehensive Offering, Combining the Most Advanced Metal Manufacturing Solution with Most Comprehensive Polymer and Operational Capabilities Combined Company

DDD